Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-Assisted Psychotherapy for Anxiety in Advanced Cancer
NCT00252174Phase 2Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Feb 2007
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of midomafetamine in anxiety disorder, sponsored by Brigham and Women's Hospital. Started Feb 2007; status: terminated.
02
Drugs
midomafetamine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT00252174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252174.